| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |